This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (250)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Thomas H. McGlashan, MD; William T. Carpenter, Jr, MD

Arch Gen Psychiatry. 1976;33(2):231-239.

Abstract
• Several authors have described a severe depression in patients emerging from psychotic states. The clinical picture usually resembles that of a retarded depression with strong neurasthenic and schizoid components. It frequently emerges after a patient has been discharged from the hospital and may often go unnoticed. When manifest, the syndrome is usually stable phenomenologically, is often lengthy, and may be resistant to all modalities of treatment. Postpsychotic depression is a relatively neglected clinical area despite the risk of suicide and prolonged suffering. Therapeutic perseverence purportedly can improve the patient's long-term prognosis, and the phenomenon itself may be a favorable prognostic sign. We present here a review and reformulation of this syndrome.

Author Affiliations
From the Psychiatric Assessment Section, Adult Psychiatry Branch, National Institute of Mental Health, Bethesda, Md. Dr McGlashan is now with the Chestnut Lodge, Rockville, Md. Dr Carpenter is now with the Albert Einstein College of Medicine, Bronx, NY.

Footnotes
Accepted for publication July 7, 1975.

Reprint requests to Chestnut Lodge, 500 W Montgomery Ave, Rockville, MD 20850 (Dr McGlashan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Historical perspective on antipsychotic long-acting injections
Johnson
Br. J. Psychiatry 2009;195:S7-S12.
ABSTRACT | FULL TEXT  

Psychosis as a Disorder of Reduced Cathectic Capacity: Freud's Analysis of the Schreber Case Revisited
McGlashan
Schizophr Bull 2009;35:476-481.
ABSTRACT | FULL TEXT  

Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia
Mohamed et al.
Schizophr Bull 2009;35:336-346.
ABSTRACT | FULL TEXT  

Correlates and Long-Term Consequences of Poor Insight in Patients With Schizophrenia. A Systematic Review
Lincoln et al.
Schizophr Bull 2007;33:1324-1342.
ABSTRACT | FULL TEXT  

Rationale and Parameters for Medication-Free Research in Psychosis
McGlashan
Schizophr Bull 2006;32:300-302.
FULL TEXT  

Diagnosis and Treatment of Mood Disorders That Co-occur With Schizophrenia
Escamilla
Psychiatr. Serv. 2001;52:911-919.
ABSTRACT | FULL TEXT  

Suicide and schizophrenia
Siris
J Psychopharmacol 2001;15:127-135.
ABSTRACT  

Depression in Schizophrenia: Perspective in the Era of "Atypical" Antipsychotic Agents
Siris
Am. J. Psychiatry 2000;157:1379-1389.
ABSTRACT | FULL TEXT  

Treatment of Schizoaffective Disorder and Schizophrenia With Mood Symptoms
Levinson et al.
Am. J. Psychiatry 1999;156:1138-1148.
ABSTRACT | FULL TEXT  

Emerging Applications of Newer Antipsychotic Agents in Specific Patient Populations
Littrell and Littrell
J Am Psychiatr Nurses Assoc 1998;4:S42-S52.
ABSTRACT  

Maintenance Imipramine Therapy for Secondary Depression in Schizophrenia: A Controlled Trial
Siris et al.
Arch Gen Psychiatry 1994;51:109-115.
ABSTRACT  

Antidepressants in 'Depressed' Schizophrenic Inpatients: A Controlled Trial
Kramer et al.
Arch Gen Psychiatry 1989;46:922-928.
ABSTRACT  

Cholinergic Hyperactivity and Negative Schizophrenic Symptoms: A Model of Cholinergic/Dopaminergic Interactions in Schizophrenia
Tandon and Greden
Arch Gen Psychiatry 1989;46:745-753.
ABSTRACT  

Adjunctive Imipramine in the Treatment of Postpsychotic Depression: A Controlled Trial
Siris et al.
Arch Gen Psychiatry 1987;44:533-539.
ABSTRACT  

Schizophrenia Subdivided by the Family History of Affective Disorder: A Comparison of Symptomatology and Course of Illness
Kendler and Hays
Arch Gen Psychiatry 1983;40:951-955.
ABSTRACT  

Intensive Individual Psychotherapy of Schizophrenia: A Review of Techniques
McGlashan
Arch Gen Psychiatry 1983;40:909-920.
ABSTRACT  

Development and Prediction of Postpsychotic Depression in Neuroleptic-Treated Schizophrenics
Mandel et al.
Arch Gen Psychiatry 1982;39:197-203.
ABSTRACT  

Postpsychotic Depressive Symptoms in Hospitalized Schizophrenic Patients
Siris et al.
Arch Gen Psychiatry 1981;38:1122-1123.
ABSTRACT  

'Revealed' Depression and Drug Treatment for Schizophrenia
Knights and Hirsch
Arch Gen Psychiatry 1981;38:806-811.
ABSTRACT  

Depression in the Course of Chronic Undifferentiated Schizophrenia
Roy
Arch Gen Psychiatry 1981;38:296-297.
ABSTRACT  

Treatment of Secondary Depression in Schizophrenia: A Double-blind, Placebo-Controlled Trial of Amitriptyline Added to Perphenazine
Prusoff et al.
Arch Gen Psychiatry 1979;36:569-575.
ABSTRACT  

Use of Antidepressant Drugs in Schizophrenia
Siris et al.
Arch Gen Psychiatry 1978;35:1368-1377.
ABSTRACT  

'Akinetic Depression' in Schizophrenia
Van Putten and May
Arch Gen Psychiatry 1978;35:1101-1107.
ABSTRACT  

Time Experience and a Certain Type of Mourning
Hershey
J Am Psychoanal Assoc 1978;26:109-130.
 

Psychoses Precipitated by Psychotomimetic Drugs: A Follow-up Study
Bowers
Arch Gen Psychiatry 1977;34:832-835.
ABSTRACT  

Symptom Patterns in Primary and Secondary Depression: A Comparison of Primary Depressives With Depressed Opiate Addicts, Alcoholics, and Schizophrenics
Weissman et al.
Arch Gen Psychiatry 1977;34:854-862.
ABSTRACT